FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2301426291> ?p ?o ?g. }

• W2301426291 endingPage "207" @default.
• W2301426291 startingPage "199" @default.
• W2301426291 abstract "Objective Cervical cancer is responsible for more than a quarter of a million deaths globally each year, mostly in developing countries, making therapeutic advances in all health care settings a top priority. The Gynecologic Cancer InterGroup (GCIG) is a worldwide collaboration of leading national research groups that develops and promotes multinational trials in gynecologic cancer. In recognition of the pressing need for action, the GCIG convened an international meeting with expert representation from the GCIG groups and selected large sites in low- and middle-income countries. Methods The focus was to develop a consensus on several concepts for future clinical trials, which would be developed and promoted by the GCIG and launched with major international participation. The first half of the meeting was devoted to a resume of the current state of the knowledge and identifying the gaps in need of new evidence, validating control arms for present and future clinical trials and identifying national and international barriers for studies of cervix cancers. The second half of the meeting was concerned with achieving consensus on a path forward. Results and Conclusions There were 5 principal outcomes as follows: first, a proposal to expand fertility-preserving options with neoadjuvant chemotherapy; second, validation of the assessment of sentinel lymph nodes using minimally invasive surgery with an emphasis on identification and management of low-volume metastasis, such as isolated tumor cells and micrometastasis; third, evaluation of hypofractionation for palliative and curative radiation under the umbrella of the GCIG Cervix Cancer Research Network; fourth, adding to the advances in antiangiogenesis therapy in the setting of metastatic disease; and fifth, developing a maintenance study among women at high risk of relapse. The latter 2 systemic interventions could study PI3K (phosphatidylinositol-3-kinase) inhibitors, immunotherapy, anti–human papillomavirus approaches, or novel antiangiogenic agents/combinations." @default.
• W2301426291 created "2016-06-24" @default.
• W2301426291 creator A5002011120 @default.
• W2301426291 creator A5008419054 @default.
• W2301426291 creator A5009354470 @default.
• W2301426291 creator A5014611244 @default.
• W2301426291 creator A5025234993 @default.
• W2301426291 creator A5028892367 @default.
• W2301426291 creator A5031632001 @default.
• W2301426291 creator A5035698039 @default.
• W2301426291 creator A5041555565 @default.
• W2301426291 creator A5041813027 @default.
• W2301426291 creator A5044751872 @default.
• W2301426291 creator A5045621454 @default.
• W2301426291 creator A5049908989 @default.
• W2301426291 creator A5053438700 @default.
• W2301426291 creator A5057224046 @default.
• W2301426291 creator A5057313839 @default.
• W2301426291 creator A5060565441 @default.
• W2301426291 creator A5063000325 @default.
• W2301426291 creator A5073063132 @default.
• W2301426291 creator A5085752463 @default.
• W2301426291 creator A5086907081 @default.
• W2301426291 creator A5087341200 @default.
• W2301426291 date "2016-01-01" @default.
• W2301426291 modified "2023-10-01" @default.
• W2301426291 title "Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future" @default.
• W2301426291 cites W1963853602 @default.
• W2301426291 cites W1969057487 @default.
• W2301426291 cites W1969525589 @default.
• W2301426291 cites W1973962628 @default.
• W2301426291 cites W1988124776 @default.
• W2301426291 cites W2017795824 @default.
• W2301426291 cites W2023410485 @default.
• W2301426291 cites W2030526345 @default.
• W2301426291 cites W2038045035 @default.
• W2301426291 cites W2045401584 @default.
• W2301426291 cites W2050249255 @default.
• W2301426291 cites W2073779538 @default.
• W2301426291 cites W2093526263 @default.
• W2301426291 cites W2099530756 @default.
• W2301426291 cites W2100756525 @default.
• W2301426291 cites W2108107021 @default.
• W2301426291 cites W2112376077 @default.
• W2301426291 cites W2118508302 @default.
• W2301426291 cites W2126834211 @default.
• W2301426291 cites W2134787029 @default.
• W2301426291 cites W2139803219 @default.
• W2301426291 cites W2159560082 @default.
• W2301426291 cites W2164758846 @default.
• W2301426291 cites W2166872093 @default.
• W2301426291 cites W2170781431 @default.
• W2301426291 doi "https://doi.org/10.1097/igc.0000000000000587" @default.
• W2301426291 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4831060" @default.
• W2301426291 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26569057" @default.
• W2301426291 hasPublicationYear "2016" @default.
• W2301426291 type Work @default.
• W2301426291 sameAs 2301426291 @default.
• W2301426291 citedByCount "31" @default.
• W2301426291 countsByYear W23014262912016 @default.
• W2301426291 countsByYear W23014262912017 @default.
• W2301426291 countsByYear W23014262912018 @default.
• W2301426291 countsByYear W23014262912019 @default.
• W2301426291 countsByYear W23014262912020 @default.
• W2301426291 countsByYear W23014262912021 @default.
• W2301426291 countsByYear W23014262912022 @default.
• W2301426291 countsByYear W23014262912023 @default.
• W2301426291 crossrefType "journal-article" @default.
• W2301426291 hasAuthorship W2301426291A5002011120 @default.
• W2301426291 hasAuthorship W2301426291A5008419054 @default.
• W2301426291 hasAuthorship W2301426291A5009354470 @default.
• W2301426291 hasAuthorship W2301426291A5014611244 @default.
• W2301426291 hasAuthorship W2301426291A5025234993 @default.
• W2301426291 hasAuthorship W2301426291A5028892367 @default.
• W2301426291 hasAuthorship W2301426291A5031632001 @default.
• W2301426291 hasAuthorship W2301426291A5035698039 @default.
• W2301426291 hasAuthorship W2301426291A5041555565 @default.
• W2301426291 hasAuthorship W2301426291A5041813027 @default.
• W2301426291 hasAuthorship W2301426291A5044751872 @default.
• W2301426291 hasAuthorship W2301426291A5045621454 @default.
• W2301426291 hasAuthorship W2301426291A5049908989 @default.
• W2301426291 hasAuthorship W2301426291A5053438700 @default.
• W2301426291 hasAuthorship W2301426291A5057224046 @default.
• W2301426291 hasAuthorship W2301426291A5057313839 @default.
• W2301426291 hasAuthorship W2301426291A5060565441 @default.
• W2301426291 hasAuthorship W2301426291A5063000325 @default.
• W2301426291 hasAuthorship W2301426291A5073063132 @default.
• W2301426291 hasAuthorship W2301426291A5085752463 @default.
• W2301426291 hasAuthorship W2301426291A5086907081 @default.
• W2301426291 hasAuthorship W2301426291A5087341200 @default.
• W2301426291 hasBestOaLocation W23014262911 @default.
• W2301426291 hasConcept C121608353 @default.
• W2301426291 hasConcept C126322002 @default.
• W2301426291 hasConcept C2777740455 @default.
• W2301426291 hasConcept C2778123414 @default.
• W2301426291 hasConcept C2778220009 @default.
• W2301426291 hasConcept C2779013556 @default.
• W2301426291 hasConcept C29456083 @default.

• next